Matthew Wilson, M.D., Ph.D.


Matthew Wilson, M.D., Ph.D. is an associate professor of medicine at the Vanderbilt University Medical Center and has been an active member of ASGCT since 2004. He originally joined the Society as a postdoctoral fellow and now serves on the Physical Delivery Therapeutics and Vector Development and Genome Editing committees, chairing the former in 2018-2019. His laboratory is currently focused on developing approaches and technologies for cell and gene therapy of kidney diseases.

2019
ASGCT Policy Summit
November 4 – 6 | Washington D.C.
Close